Target intelligence / Profile preview

Wnt family member 8A (WNT8A)

Target: WNT8A
Molecular classification: Ligand (secreted signaling protein), Member of Wnt family, Protein involved in cell signaling, Developmental morphogen, Endogenous peptide, Not a receptor, enzyme, ion channel, transporter, or transcription factor itself, but a ligand for Frizzled receptors

Overview

Wnt family member 8A (WNT8A) is a secreted signaling protein of the Wnt family, encoded by the WNT8A gene in humans. It functions as a ligand for Frizzled family receptors, activating the canonical Wnt/β-catenin pathway to regulate embryonic axis patterning, neural crest induction, cell fate, morphogenesis, and stem cell renewal. WNT8A signaling underlies key developmental processes and is implicated in several diseases including various cancers, neurodevelopmental disorders, and some forms of arthritis. WNT8A is not currently targeted by specific drugs, but the pathway it modulates is being investigated intensively for therapeutic intervention. Safety issues arise from its fundamental roles in development and regeneration, limiting direct drug development.

Other names: Protein Wnt-8aWNT8DProtein Wnt-8dWNT8dWingless-type MMTV integration site family, member 8AWnt family member 8A

Mechanism of action

Wnt pathway inhibition: Most Wnt-targeting therapies aim to inhibit the Wnt/β-catenin pathway, either by blocking Wnt ligands, Frizzled receptors, or downstream signaling. Antibodies or small molecules targeting ligand-receptor interaction (experimental)

Biological functions

Signal transduction (Wnt/β-catenin pathway)Regulation of cell fate and patterning during embryogenesisNeural crest induction and axis specification in early developmentStem cell renewal and morphogenesisRoles in epithelial-mesenchymal transition, pluripotency, and tissue regeneration

Disease associations

Cancer (oncogenesis; found in molecular cancer mechanisms, e.g., colorectal, ovarian, glioblastoma, chronic myeloid leukemia)Germ cell tumorsNeurodevelopmental disorders (e.g., dysmorphic facies, distal limb anomalies)Rheumatoid arthritis (role in chondrocytes, osteoblasts, osteoclasts)OsteoarthritisFebrile seizures, familialOther: tissue regeneration and developmental anomalies

Safety considerations

Therapeutic targeting is challenging due to broad roles in normal development and tissue homeostasis; inhibition could cause developmental toxicity or impair tissue regenerationLack of WNT8A specificity: Wnt pathways are redundant and broadly expressedOff-target effects and tissue patterns must be considered

Biomarkers

Expression of WNT8A itself (e.g., by qPCR, dPCR; monitored in stem cell, cancer, or developmental disorder contexts)Activation of downstream genes in Wnt pathway (e.g., β-catenin, AXIN, SOX10, PAX3, FOXD3)May be part of multi-gene panels in cancer or stem cell research

Beyond the preview

Go deeper on Wnt family member 8A (WNT8A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wnt family member 8A (WNT8A).

Explore the full profile